Name: UMIN ID:
Unique ID issued by UMIN | UMIN000036970 |
---|---|
Receipt number | R000041954 |
Scientific Title | Biomarker analysis: Phase II study of nivolumab + abemaciclib + endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer (NEWFLAME) WJOG11418B-TR |
Date of disclosure of the study information | 2019/06/05 |
Last modified on | 2023/01/10 09:53:13 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/06/05 10:40:02 | ||
2 | Update | 2019/09/13 16:33:23 | Recruitment status Date of IRB Last follow-up date |
|
3 | Update | 2022/03/01 13:37:03 | Recruitment status |
|
4 | Update | 2023/01/10 09:53:13 | Recruitment status |